Table 3. SOX2 expressions and clinicopathological characteristics of GC.
Clinical and pathological data | Case number | SOX2 | Positive rate (%) | P | |
---|---|---|---|---|---|
Negative | Positive | ||||
Age (year) | |||||
< 60 | 28 | 19 | 9 | 32.14 | 0.397 |
≥ 60 | 32 | 25 | 7 | 21.88 | |
Sex | |||||
male | 29 | 23 | 6 | 20.69 | 0.387 |
female | 31 | 21 | 10 | 32.26 | |
Tumor location | |||||
Near the pylorus | 33 | 25 | 8 | 24.24 | 0.771 |
Near the cardia | 27 | 19 | 8 | 29.63 | |
Differentiation degree | |||||
Moderately to well differentiated | 36 | 22 | 14 | 38.89 | 0.015 |
Poorly to non-differentiated | 24 | 22 | 2 | 8.33 | |
LNM | |||||
without metastasis | 33 | 18 | 15 | 45.45 | 2.745E-4 |
with metastasis | 27 | 26 | 1 | 3.70 | |
TNM staging | |||||
I/II staging | 30 | 16 | 14 | 46.67 | 4.596E-4 |
III/IV staging | 30 | 28 | 2 | 6.67 |
GC, gastric cancer.